Journal Publications

No. Author Title Journal Name Year (Month/Day)
1573 Ylade M, Aziz AB, Daag JV, Crisostomo MV, Agrupis KA, Maronilla MA, Sye Lim Hong C, Kim HY, Njau I, Lopez MHJ, Deen J, Kim DR, You YA, Kang SSY, Marks F, Tadesse BT Using Dried Blood Spots to Quantitatively Detect Anti-SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study. Am J Trop Med Hyg 2024 (Aug)
1572 Rogers Van Katwyk S, Poirier MJP, Chandy SJ, Faure K, Fisher C, Lhermie G, Moodley A, Sarkar S, Sophie M, Strong K, Weldon I, Hoffman SJ 1-10-100: Unifying goals to mobilize global action on antimicrobial resistance. Global Health 2024 (Aug)
1571 Moon SY, Flores RA, Yim MS, Lim H, Kim S, Lee SY, Lee YK, Kim JO, Park H, Bae SE, Ouh IO, Kim WH Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus. Vaccines (Basel) 2024 (Aug)
1570 Nuwangi H, Dikomitis L, Weerakoon KG, Liyanage C, Agampodi TC, Agampodi SB Stigma associated with cutaneous leishmaniasis in rural Sri Lanka: development of a conceptual framework. Int Health 2024 (Sep)
1569 Jung HG, Jeong S, Kang MJ, Hong I, Park YS, Ko E, Kim JO, Choi DY Molecular Design of Encapsulin Protein Nanoparticles to Display Rotavirus Antigens for Enhancing Immunogenicity. Vaccines (Basel) 2024 (Sep)
1568 Seo SH, Choi JA, Jung DI, Park Y, Yang E, Jung S, Kwon T, Kwon SH, Song M Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice. Virol J 2024 (Sep)
1567 Aziz AB, Sugimoto JD, Hong SL, You YA, Bravo L, Roa C Jr, Borja-Tabora C, Montellano MEB, Carlos J, de Los Reyes MRA, Alberto ER, Salvani-Bautista M, Kim HY, Njau I, Clemens R, Marks F, Tadesse BT Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: A cluster randomised analysis. J Infect 2024
1566 Kim JH, Parajulee P, Nguyen TT, Wasunkar S, Mogasale V, Park SE, Panzner U, Mogeni OD, Im J, Marks F Occurrence of human infection with Salmonella Typhi in sub-Saharan Africa. Sci Data 2024
1565 Qadri F, Khanam F, Zhang Y, Biswas PK, Voysey M, Mujadidi YF, Kelly S, Bhuiyan AI, Rajib NH, Hossen I, Rahman N, Islam S, Pitzer VE, Kim YC, Clemens JD, Pollard AJ, Liu X 5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial. Lancet 2024
1564 Kelly M, Janardhanan J, Wagh C, Verma S, Charles RC, Leung DT, Kamruzzaman M, Pansuriya RK, Chowdhury F, Vann WF, Kaminski RW, Khan AI, Bhuiyan TR, Qadri F, Kovac P, Xu P, Ryan ET Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge. Vaccine 2024
1563 Agampodi S, Tadesse BT, Sahastrabuddhe S, Excler JL, Kim JH Biases in COVID-19 vaccine effectiveness studies using cohort design. Front Med (Lausanne) 2024
1562 Jiamsiri S, Rhee C, Ahn HS, Seo HW, Klinsupa W, Park S, Lee J, Premsri N, Namwat C, Silaporn P, Excler JL, Kim DR, Chon Y, Sampson JN, Nilyanimit P, Vongpunsawad S, Poudyal N, Markowitz LE, Panicker G, Unger ER, Rerks-Ngarm S, Poovorawan Y, Lynch J Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination. J Natl Cancer Inst Monogr 2024
1561 Gunasekara SD, Agampodi TC, Weerasinghe M, Fernando MS, Price HP, Wickramasinghe ND, Agampodi SB Investigating disease awareness of cutaneous leishmaniasis in rural Sri Lanka to inform public health services: a cross-sectional study. BMJ Open 2024
1560 Jung SM, Kim SJ, Park YC, Seo ES, Kim CG, Kim T, Lee S, Cho E, Chang J, Yun CH, Shim BS, Cheon IS, Son YM RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity. Vaccines (Basel) 2024
1559 Cagigi A, Tinnirello R, Iannolo G, Douradinha B Orthoflavivirus zikaense (Zika) vaccines: What are we waiting for? Int J Antimicrob Agents 2024
No.1573 Author Ylade M, Aziz AB, Daag JV, Crisostomo MV, Agrupis KA, Maronilla MA, Sye Lim Hong C, Kim HY, Njau I, Lopez MHJ, Deen J, Kim DR, You YA, Kang SSY, Marks F, Tadesse BT
Title Using Dried Blood Spots to Quantitatively Detect Anti-SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study.
Journal Name Am J Trop Med Hyg
Month / Year 02/2025
No.1572 Author Rogers Van Katwyk S, Poirier MJP, Chandy SJ, Faure K, Fisher C, Lhermie G, Moodley A, Sarkar S, Sophie M, Strong K, Weldon I, Hoffman SJ
Title 1-10-100: Unifying goals to mobilize global action on antimicrobial resistance.
Journal Name Global Health
Month / Year 02/2025
No.1571 Author Moon SY, Flores RA, Yim MS, Lim H, Kim S, Lee SY, Lee YK, Kim JO, Park H, Bae SE, Ouh IO, Kim WH
Title Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus.
Journal Name Vaccines (Basel)
Month / Year 02/2025
No.1570 Author Nuwangi H, Dikomitis L, Weerakoon KG, Liyanage C, Agampodi TC, Agampodi SB
Title Stigma associated with cutaneous leishmaniasis in rural Sri Lanka: development of a conceptual framework.
Journal Name Int Health
Month / Year 02/2025
No.1569 Author Jung HG, Jeong S, Kang MJ, Hong I, Park YS, Ko E, Kim JO, Choi DY
Title Molecular Design of Encapsulin Protein Nanoparticles to Display Rotavirus Antigens for Enhancing Immunogenicity.
Journal Name Vaccines (Basel)
Month / Year 02/2025
No.1568 Author Seo SH, Choi JA, Jung DI, Park Y, Yang E, Jung S, Kwon T, Kwon SH, Song M
Title Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice.
Journal Name Virol J
Month / Year 02/2025
No.1567 Author Aziz AB, Sugimoto JD, Hong SL, You YA, Bravo L, Roa C Jr, Borja-Tabora C, Montellano MEB, Carlos J, de Los Reyes MRA, Alberto ER, Salvani-Bautista M, Kim HY, Njau I, Clemens R, Marks F, Tadesse BT
Title Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: A cluster randomised analysis.
Journal Name J Infect
Month / Year 02/2025
No.1566 Author Kim JH, Parajulee P, Nguyen TT, Wasunkar S, Mogasale V, Park SE, Panzner U, Mogeni OD, Im J, Marks F
Title Occurrence of human infection with Salmonella Typhi in sub-Saharan Africa.
Journal Name Sci Data
Month / Year 02/2025
No.1565 Author Qadri F, Khanam F, Zhang Y, Biswas PK, Voysey M, Mujadidi YF, Kelly S, Bhuiyan AI, Rajib NH, Hossen I, Rahman N, Islam S, Pitzer VE, Kim YC, Clemens JD, Pollard AJ, Liu X
Title 5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.
Journal Name Lancet
Month / Year 02/2025
No.1564 Author Kelly M, Janardhanan J, Wagh C, Verma S, Charles RC, Leung DT, Kamruzzaman M, Pansuriya RK, Chowdhury F, Vann WF, Kaminski RW, Khan AI, Bhuiyan TR, Qadri F, Kovac P, Xu P, Ryan ET
Title Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.
Journal Name Vaccine
Month / Year 02/2025
No.1563 Author Agampodi S, Tadesse BT, Sahastrabuddhe S, Excler JL, Kim JH
Title Biases in COVID-19 vaccine effectiveness studies using cohort design.
Journal Name Front Med (Lausanne)
Month / Year 02/2025
No.1562 Author Jiamsiri S, Rhee C, Ahn HS, Seo HW, Klinsupa W, Park S, Lee J, Premsri N, Namwat C, Silaporn P, Excler JL, Kim DR, Chon Y, Sampson JN, Nilyanimit P, Vongpunsawad S, Poudyal N, Markowitz LE, Panicker G, Unger ER, Rerks-Ngarm S, Poovorawan Y, Lynch J
Title Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination.
Journal Name J Natl Cancer Inst Monogr
Month / Year 02/2025
No.1561 Author Gunasekara SD, Agampodi TC, Weerasinghe M, Fernando MS, Price HP, Wickramasinghe ND, Agampodi SB
Title Investigating disease awareness of cutaneous leishmaniasis in rural Sri Lanka to inform public health services: a cross-sectional study.
Journal Name BMJ Open
Month / Year 02/2025
No.1560 Author Jung SM, Kim SJ, Park YC, Seo ES, Kim CG, Kim T, Lee S, Cho E, Chang J, Yun CH, Shim BS, Cheon IS, Son YM
Title RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity.
Journal Name Vaccines (Basel)
Month / Year 02/2025
No.1559 Author Cagigi A, Tinnirello R, Iannolo G, Douradinha B
Title Orthoflavivirus zikaense (Zika) vaccines: What are we waiting for?
Journal Name Int J Antimicrob Agents
Month / Year 02/2025